Viewing Study NCT00915603


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2025-12-30 @ 2:47 PM
Study NCT ID: NCT00915603
Status: COMPLETED
Last Update Posted: 2014-12-22
First Post: 2009-06-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
Sponsor: SCRI Development Innovations, LLC
Organization: